Screener
Sana Biotechnology SANA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 17,336 | 66,512 |
| Restricted cash | 4,195 | 4,195 |
| Prepaid expenses and other current assets | 6,359 | 6,099 |
| Total current assets | 111,690 | 148,676 |
| Property and equipment, net | 25,673 | 26,906 |
| Operating lease right-of-use assets | 35,845 | 38,313 |
| Intangible asset | 59,195 | 59,195 |
| Goodwill | 140,627 | 140,627 |
Item 1. Financial Statements
FAQ
- What is Sana Biotechnology's total current assets?
- Sana Biotechnology (SANA) reported total current assets of $111.69M in Q1 2026.
- How has Sana Biotechnology's total current assets changed year-over-year?
- Sana Biotechnology's total current assets decreased by 0.9% year-over-year, from $112.73M to $111.69M.
- What is the long-term trend for Sana Biotechnology's total current assets?
- Over 5 years (2020 to 2025), Sana Biotechnology's total current assets has grown at a -17.3% compound annual growth rate (CAGR), from $384.47M to $148.68M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Sana Biotechnology's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude